Immunology of tuberculosis and implications in vaccine development

Tuberculosis

Volumn 84, Issue 1-2, 2004, Pages 93-101

  Flynn, JoAnne L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Lung; Macrophages; Mycobacteria; T cells; Tuberculosis

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

BCG VACCINATION; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFECTION PREVENTION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

EID: 0347269081     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2003.08.010     Document Type: Conference Paper

References (92)

1. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Freidland GH. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
2. Lurie M. Studies on the mechanism of immunity in tuberculosis. The fate of tubercle bacilli ingested by mononuclear phagocytes derived from normal and immunized animals. J Exp Med 1942;75:247.
3. Suter E. The multiplication of tubercle bacilli within normal phagocytes in tissue cultures. J Exp Med 1952;96:137.
4. Mackaness G. The influence of immunologically committed lynphoid cells on macrophage activation in vivo. J Exp Med 1969;129:973.
5. Rook GAW, Steele J, Ainsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma interferon on human monocytes and murine peritoneal macrophages. Immunology 1986;59:333-8.
6. Flesch I, Kaufmann S. Mycobacterial growth inhibition by interferon-g activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol 1987;138:4408-13.
7. Flesch IEA, Kaufmann SHE. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun 1990;58:2675-7.
8. Ding AH, Nathan C, Stuehr D. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 1988;141: 2407-12.
9. Chan J, Tanaka K, Carroll D, Flynn JL, Bloom BR. Effect of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995;63:736-40.
10. MacMicking J, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997;94:5243-8.
11. Flynn JL, Scanga CA, Tanaka KE, Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998;160:1796-803.
12. Scanga CA, Mohan VP, Tanaka K, Alland D, Flynn JL, Chan J. The NOS2 locus confers protection in mice against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis. Infect Immun 2001;69:7711-7.
13. Ottenhof TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-1 cytokines In immunity to intracellular bacteria. Immunol Today 1998;19:491-4.
14. Nicholson S, Bonecini-Almeida M, Silva JRL, Nathan C, Xie Q-W, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, Linhares C, Rom W, Ho JL. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;184:2293-302.
15. Bonecini-Almeida M, Chitale S, Boutsikakis I, Geng J, Doo H, He S, Ho JL. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. J Immunol 1998;160: 4490-9.
16. Rockett K, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66:5314-21.
17. Wang C-H, Liu C-Y, Lin H-C, Yu C-T, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998;11:809-15.
18. McKinney JD, zu Bentrup KH, Miczak A, Chen B, Chan W-T, Swenson D, Sacchettini JC, Jacobs Jr. WR, Russell DG. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000;406:735-8.
19. Armstrong J, D'Arcy Hart P. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 1971; 134:713-40.
20. Hart PD, Brown CA, Armstrong JA, Draper P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun 1972;5:803-7.
21. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL, Heuser J, Russell DG. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994;263:678-81.
22. Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997;159:635-43.
23. Ladel CH, Szalay G, Reidel D, Kaufmann SH. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect Immun 1997;65:1936-8.
24. Sano K, Handea K, Tamura G, Shirato K. Ovalbumin (OVA) and Myocbacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper cells foward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia. Am J Resp Cell Mol Biol 1999;20:1260-7.
25. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155: 2515-24.
26. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997;186:39-45.
27. Lowrie DB, Tascon RE, Bonato VLD, Lima VMF, Faccioli LH, Stavropoulos E, Colston MJ, Hewinson RG, Moelling K, Silva CL. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999;400:269-71.
28. Orme I, Miller E, Roberts A, Furney S, Griffen J, Dobos K, Chi D, Rivoire B, Brennan P. T Lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. J Immunol 1992; 148:189-96.
29. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by Mycobacterium-reactive human T-cell clones. Infect Immun 1993;61:197-203.
30. Orme IM, Roberts AD, Griffen JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993; 151:518-25.
31. Lalvani A, Brookes R, Wilkinson R, Malin A, Pathan A, Andersen P, Dockrell H, Pasvol G, Hill A. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998;95:270-5.
32. Lyadova I, Yeremeev V, Majorov K, Nikonenko B, Khaidukov S, Kondratieva T, Kobets N, Apt A. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect Immun 1998;66:4981-8.
33. Serbina NV, Flynn JL. Early emergence of CD8+ T cells primed for production of Type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immunology 1999;67:3980-8.
34. Cooper AM, Dalton DK, Stewart TA, Griffen JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J Exp Med 1993;178:2243-8.
35. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
36. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259:1739-42.
37. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-4.
38. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent TH2 cytokine response in human tuberculosis. Infect Immun 1996;64:1351-6.
39. Ting LM, Kim AC, Cattamanchi A, Ernst JD. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol 1999;163:3898-906.
40. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-α is required in the protective immune response against M tuberculosis in mice. Immunity 1995; 2:561-72.
41. Bean AGD, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999;162:3504-11.
42. Liew FY, Li Y, Millott S. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990;145: 4306-10.
43. Chan J, Xing Y, Magliozzo R, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-22.
44. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, Flynn JL, Chan J. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001;69:1847-55.
45. Kindler V, Sappino A-P, Grau GE, Piguet P-F, Vassalli P. The Inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56:731-40.
46. Garcia I, Miyazaki Y, Marchal G, Lesslauer W, Vassalli P. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas. Eur J Immunol 1997;27:3182-90.
47. Ehlers S, Benin J, Kutsch S, Endres R, Rietschel ET, Pfeffer K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun 1999;67:3571-9.
48. Rook GAW, Taverne J, Leveton C, Steele J. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 1987;62:229-34.
49. Rook GAW. Mycobacteria, cytokines and antibiotics. Pathol Biol (Paris) 1990;38:276-80.
50. Moreira AL, Tsenova-Berkova L, Wang J, Laochumroonvorapong P, Freeman S, VH, Freedman GK. Effect of cytokine modulation by thalidomide on the granomatous response in murine tuberculosis. Tubercle Lung Dis 1997; 78:47-55.
51. Bekker L-G, Moreira AL, Bergtold A, Freeman S, Ryffel B, Kaplan G. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose-dependent. Infect Immun 2000;68:6954-61.
52. Hodge-Dufour J, Marino MW, Horton MR, Jungbluth A, Durdick MD, Strieter RM, Noble PW, Hunter CA, Pure E. Inhibition of interferon γ induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci USA 1998; 95:13806-11.
53. Maini R, St. Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldman M, Lipsky P. Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932-9.
54. Feng CG, Bean AGD, Hooi H, Briscoe H, Britton WJ. Increase in gamma interferon-secreting CD8+, as well as CD4+, T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun 1999;67:3242-7.
55. Serbina NV, Liu C-C, Scanga CA, Flynn JL. CD8+ cytotoxic T lymphocytes from lungs of M. tuberculosis infected mice express perform in vivo and lyse Infected macrophages. J Immunol 2000;165:353-63.
56. Randhawa PS. Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies. Pathology 1990;22:153-5.
57. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-7.
58. Muller I, Cobbold S, Waldmann H, Kaufmann SHE. Impaired resistance to Mycobacterium tuberculosis Infection after selective in vivo depletion of L3T4+ and Lyt2+ T cells. Infect Immun 1987;55:2037-41.
59. Tascon RE, Stavropoulos E, Lukacs KV, Colston MJ. Protection against Mycobacterium tuberculosis infection by CD8 T cells requires production of gamma interferon. Infect Immun 1998;66:830-4.
60. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J Immunol 1999;162:5407-16.
61. Orme I, Collins F. Adoptive protection of the Mycobacteria tuberculosis-infected lung. Cell Immunol 1984;84:113-20.
62. Orme I, Collins F. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. J Exp Med 1983;158:74-83.
63. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, Kornfeld H. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997;65:298-304.
64. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J Immunol 1998;161:2636-41.
65. Mazzaccaro RJ, Gedde M, Jensen ER, van Santem HM, Ploegh HL, Rock KL, Bloom BR. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1996; 93:11786-91.
66. Hmama Z, Gabathuler R, Jefferies WA, Dejong G, Reiner NE. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature Class II heterodimers. J Immunol 1998;161:4882-93.
67. Wojciechowski W, DeSanctis J, Skamene E, Radzioch D. Attenuation of MHC Class II expression in macrophages infected with Mycobacterium bovis BCG involves Class II transactivator and depends on the Nramp1 gene. J Immunol 1999;163:2688-96.
68. Noss EH, Harding CV, Boom WH. Mycobacterium tuberculosis inhibits MHC Class II antigen processing in murine bone marrow macrophages. Cell Immunol 2000;201:63-74.
69. Stenger S, Niazi KR, Modlin RL. Down-regulation of CD1 on antigen presenting cells by infection with Mycobacterium tuberculosis. J Immunol 1998;161:3582-8.
70. Bodnar KA, Serbina NV, Flynn JL. Interaction of Mycobacterium tuberculosis with murine dendritic cells. Infect Immun 2001;69:800-9.
71. Gong J-H, Zhang M, Modlin RL, Linsley PS, Iyer D, Lin Y, Barnes PF. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA4 expression. Infect Immun 1996;64:913-8.
72. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA 1997;94:3926-31.
73. Rojas RE, Balaji KN, Subramanian A, Boom WH. Regulation of human CD4+ αβ TCR+ and γδ TCR+ T cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β. Infect Immun 1999;67:6461-72.
74. Teitelbaum R, Cammer M, Maitland ML, Freitag NE, Condeelis J, Bloom BR. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci USA 1999;96:15190-5.
75. Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH. Activation of human CD8+ αβ TCR+ cells by Mycobacterium tuberculosis via an alternate Class I MHC antigen processing pathway. J Immunol 1999;162:372-9.
76. De Libero G, Flesch I, Kaufmann SHE. Mycobacteria-reactive Lyt-2+ Tcell lines. Eur J Immunol 1988;18:59-66.
77. Silva CL, Silva MF, Pietro R, Lowrie DB. Protection against tuberculosis by passive transfer with T-cell clones recognizing mycobacterial heat shock protein 65. Immunology 1994; 83:341-6.
78. Stenger S, Mazzaccaro R, Uyemura K, Cho S, Barnes P, Rosat J, Sette A, Brenner M, Porcelli S, Bloom B, Modlin R. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997;276:1684-7.
79. Tan JS, Canady DH, Boom WH, Balaji KN, Schwander SK, Rich EA. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis infection. J Immunol 1997;159:290-7.
80. Zhu X, Stauss HJ, Ivanyi J, Vordermeier HM. Specificity of CD8+ Tcells from subunit vaccinated or infected H-2b mice recognizing the 38kDa antigen of Mycobacterium tuberculosis. Int Immunol 1997;9:1669.
81. Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19kDa lipoprotein. J Immunol 1998; 161:2400-6.
82. Lewinsohn D, Alderson M, Briden A, Riddell S, Reed S, Grabstein K. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen presenting cells. J Exp Med 1998;187:1633-40.
83. Lewinsohn DM, Briden AL, Reed SG, Grabstein KH, Alderson MR. Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J Immunol 2000;165:925-30.
84. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999;189: 1973-80.
85. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, Hong S, Van Kaer L, Bloom BR. Relative contributions of distinct MHC Class I-dependent cell populations in protection to tuberculosis infection in mice. Prac Natl Acad Sci USA 1999;97:4204-8.
86. van Pinxteren LAH, Cassidy JP, Smedegaard BHC, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000;30:3689-98.
87. Rolph MS, Raupach B, Kobernick HHC, Collins HL, Perarnau B, Lemonnier FA, Kaufmann SHE. MHC Class la-restricted T cells partially account for β2-microglobulin-dependent resistance to Mycobacterium tuberculosis. Eur J Immunol 2001;31:1944-9.
88. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative Importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001;193:271-80.
89. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Ann Rev Immunol 1999;17:297-329.
90. Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, Flynn JL, Wang C-R. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med 2001;193:1213-20.
91. Scanga CA, Mohan VP, Yu K, Joseph H, Tanaka K, Chan J, Flynn JL. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of IFN-γ and NOS2. J Exp Med 2000;192:347-58.
92. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thomauszynski S, Melian A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL. An antimicrobial activity of cytotoxic T cells mediated by granulysin. Science 1998;282:121-5.